Comparative Pharmacology
Head-to-head clinical analysis: EPICORT versus HC 1.
Peer-Reviewed Evidence
Head-to-head clinical analysis: EPICORT versus HC 1.
EPICORT vs HC #1
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Epicort is a corticosteroid that exerts anti-inflammatory and immunosuppressive effects by binding to the glucocorticoid receptor, leading to modulation of gene expression and inhibition of phospholipase A2, thereby reducing prostaglandin and leukotriene synthesis.
Unknown
IV: 50 mg every 8 hours over 30 minutes.
Hydrocortisone: 100-200 mg IV as initial dose, then 50-100 mg IV every 6 hours, or 0.18 mg/kg/h IV continuous infusion.
None Documented
None Documented
Terminal half-life is 1.5–2 hours in adults; prolonged to 3–4 hours in severe hepatic impairment
2–4 hours (terminal); prolonged in renal impairment.
Renal (70% as unchanged drug and inactive metabolites), biliary/fecal (30%)
Renal: 90% as unchanged drug; fecal: 10%.
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid